New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
08:06 EDTRTRXRetrophin completes acquisition of Manchester Pharmaceuticals
Retrophin announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5M, including an upfront payment of $29.5M, plus other payments based on product sales. Retrophin intends to pursue U.S. regulatory approval for Chenodal in cerebrotendinous xanthomatosis.
News For RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 5, 2015
16:42 EDTRTRXRetrophin's RE-024 granted orphan drug designation by FDA
Subscribe for More Information
10:02 EDTRTRXRetrophin PKAN treatment granted orphan status
The FDA granted Retrophin orphan status for its treatment of pantothenate kinase associated neurodegeneration, or PKAN.
April 30, 2015
16:49 EDTRTRXRetrophin announces FDA review of IND for RE-024
Subscribe for More Information
11:35 EDTRTRXFormer Retrophin CEO Shkreli says shorting MannKind
Subscribe for More Information
April 28, 2015
10:05 EDTRTRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:41 EDTRTRXRetrophin initiated with a Buy at Deutsche Bank
Target $50.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use